Why don't we give injection lasix in rush

Reading File

Finding Sources

Reading File

Here is a thorough answer based on authoritative pharmacology and otolaryngology textbooks:

Why Injection Lasix (Furosemide) Should NOT Be Given as a Rapid (Rush) IV Bolus

The Core Reason: Ototoxicity

Furosemide (Lasix) is a loop diuretic that works by blocking sodium/water reabsorption in the loop of Henle. When given as a rapid IV bolus (rush injection), it causes a sudden spike in peak plasma concentration — and at high peak levels, it becomes directly toxic to the inner ear (cochlea).

Mechanism of Ototoxicity

Furosemide alters ion transport in the stria vascularis of the cochlea, disrupting:

Endolymphatic ion concentration
The endocochlear potential (the electrical gradient needed for hearing)

This results in damage to cochlear hair cells, leading to:

Bilateral, symmetric sensorineural hearing loss (SNHL) — often sudden in onset
Tinnitus
Vestibular damage (vertigo, ataxia) in some cases

The hearing loss is typically reversible if caught early, but can be permanent with high doses or in high-risk patients.

Risk Factors That Increase Ototoxicity

Rapid IV infusion (bolus/rush) — the most critical controllable risk factor
Renal failure — impaired drug clearance leads to high sustained plasma levels
Concomitant aminoglycoside use (e.g., gentamicin, amikacin) — potentiates ototoxicity synergistically
High total dose

What Should Be Done Instead

"In light of the potential for ototoxicity with the use of loop-active diuretics, these drugs should be administered by slow infusion rather than by bolus." — ROSEN's Emergency Medicine

The recommended IV rate for furosemide is no faster than 4 mg/min (or 0.5–1 mg/kg over ≥10–20 minutes in high doses) to keep peak plasma levels below the ototoxic threshold.

Summary Table

Factor	Risk with Rush Injection
Cochlear hair cell damage	High — from peak plasma spike
Hearing loss type	Bilateral SNHL, may be sudden
Reversibility	Usually reversible; can be permanent
Concomitant aminoglycosides	Additive/synergistic ototoxicity
Prevention	Slow IV infusion, not rapid bolus

Sources:

ROSEN's Emergency Medicine: Concepts and Clinical Practice
Cummings Otolaryngology Head and Neck Surgery (Loop Diuretics section)
KJ Lee's Essential Otolaryngology

This is a shared conversation. Sign in to Orris to start your own chat.